These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15949853)

  • 21. Using cardiac resynchronization therapy diagnostics for monitoring heart failure patients.
    Adamson PB
    Heart Fail Clin; 2009 Apr; 5(2):249-60. PubMed ID: 19249693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The importance of contractile reserve in patients with resynchronization therapy].
    Murín P; Mitro P; Valočik G; Stančák B
    Vnitr Lek; 2012 Jan; 58(1):13-7. PubMed ID: 22448695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiography and cardiac resynchronization therapy. Room for hope?
    Zamorano J
    Rev Esp Cardiol; 2008 Aug; 61(8):800-2. PubMed ID: 18684362
    [No Abstract]   [Full Text] [Related]  

  • 25. In cardiac resynchronization therapy: should we opt for AV optimization?
    Flaker G; Weachter R
    J Cardiovasc Electrophysiol; 2007 Mar; 18(3):296-7. PubMed ID: 17284284
    [No Abstract]   [Full Text] [Related]  

  • 26. Arrhythmias and the autonomic nervous system.
    Maggioni AP; Zuanetti G
    J Cardiovasc Risk; 1994 Dec; 1(4):322-31. PubMed ID: 7621316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autonomic modulation for the management of patients with chronic heart failure.
    Schwartz PJ; La Rovere MT; De Ferrari GM; Mann DL
    Circ Heart Fail; 2015 May; 8(3):619-28. PubMed ID: 25991804
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern.
    Salukhe TV; Francis DP; Clague JR; Sutton R; Poole-Wilson P; Henein MY
    Int J Cardiol; 2005 Apr; 100(1):5-12. PubMed ID: 15820279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A futuristic perspective on clinical studies of cardiac resynchronization therapy for heart failure patients.
    Tang AS; Ellenbogen KA
    Curr Opin Cardiol; 2006 Mar; 21(2):78-82. PubMed ID: 16470139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular electrophysiology in congestive heart failure and its correlation with heart rate variability and baroreflex sensitivity: a canine model study.
    Zhou SX; Lei J; Fang C; Zhang YL; Wang JF
    Europace; 2009 Feb; 11(2):245-51. PubMed ID: 19168499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate turbulence and other autonomic risk markers for arrhythmia risk stratification in dilated cardiomyopathy.
    Klingenheben T; Ptaszynski P; Hohnloser SH
    J Electrocardiol; 2008; 41(4):306-11. PubMed ID: 18342881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers.
    Crossley GH; Chen J; Choucair W; Cohen TJ; Gohn DC; Johnson WB; Kennedy EE; Mongeon LR; Serwer GA; Qiao H; Wilkoff BL;
    J Am Coll Cardiol; 2009 Nov; 54(22):2012-9. PubMed ID: 19926006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The last word.
    Heathers JA
    Exp Physiol; 2013 Jan; 98(1):348. PubMed ID: 23296309
    [No Abstract]   [Full Text] [Related]  

  • 34. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The achievements of cardiac electrotherapy].
    Schaldach M
    Vestn Khir Im I I Grek; 1995; 154(2):95-105. PubMed ID: 8540203
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac-resynchronization therapy in heart failure.
    Burri H
    N Engl J Med; 2005 Jul; 353(2):205-6; author reply 205-6. PubMed ID: 16021697
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic heart failure (VI). Ventricular arrhythmias in heart failure].
    Arribas F; García Cosío F
    Rev Esp Cardiol; 1992 Feb; 45(2):128-40. PubMed ID: 1532863
    [No Abstract]   [Full Text] [Related]  

  • 38. [T wave sensing problems with rate responsive pacemaker using Q-T interval and clinical experience].
    Kodama Y; Yano K; Hata Y; Yanaga T
    Nihon Rinsho; 1990 Feb; 48(2):380-5. PubMed ID: 2329713
    [No Abstract]   [Full Text] [Related]  

  • 39. Exercise training in chronic heart failure: beneficial effects on cardiac (11)C-hydroxyephedrine PET, autonomic nervous control, and ventricular repolarization.
    Pietilä M; Malminiemi K; Vesalainen R; Jartti T; Teräs M; Någren K; Lehikoinen P; Voipio-Pulkki LM
    J Nucl Med; 2002 Jun; 43(6):773-9. PubMed ID: 12050322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac resynchronization therapy and phase resetting of the sinoatrial node: a conjecture.
    Cantini F; Varanini M; Macerata A; Piacenti M; Morales MA; Balocchi R
    Chaos; 2007 Mar; 17(1):015106. PubMed ID: 17411263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.